RECRUITING

Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The investigators proposal is ripe for executing as the investigators seek to leverage this "natural experiment" initiated by the BJC health system to evaluate the effectiveness of the Pink \& Pearl Campaign as an implementation strategy to promote lung cancer screening (LCS) uptake among LCS-eligible women undergoing mammography at BJC West County. This evaluation is grounded in the Integrated Screening Action Model that depicts individual- and environmental-level influences on the screening behavior process. Using an explanatory sequential mixed methods design, which combines both quantitative and qualitative approaches, the research questions and specific aims for this proposal are to: a) evaluate the baseline prevalence of LCS among LCS-eligible women; b) assess whether the Pink \& Pearl Campaign increases referrals and uptake/ completion of LCS among LCS-eligible women undergoing screening mammography; and c) evaluate individual and environmental factors influencing LCS uptake, and implementation outcomes of the campaign. These implementation outcomes will help identify whether the campaign was put in place successfully or not. This proposal will inform strategies for integrating cancer screening programs to improve poorly performing programs like LCS.

Official Title

Evaluating the Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening

Quick Facts

Study Start:2025-05-08
Study Completion:2027-05-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06898333

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Beryne Odeny, M.D., MPH, Ph.D.
CONTACT
314-362-1183
beryne@wustl.edu
Vaishnavi Mamillapalle, M.D., MPH
CONTACT
614-680-4078
m.vaishnavi@wustl.edu

Principal Investigator

Beryne Odeny, M.D., MPH, Ph.D.
PRINCIPAL_INVESTIGATOR
Washington University School of Medicine

Study Locations (Sites)

Barnes-Jewish Hospital West County
Creve Coeur, Missouri, 63141
United States

Collaborators and Investigators

Sponsor: Washington University School of Medicine

  • Beryne Odeny, M.D., MPH, Ph.D., PRINCIPAL_INVESTIGATOR, Washington University School of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-05-08
Study Completion Date2027-05-31

Study Record Updates

Study Start Date2025-05-08
Study Completion Date2027-05-31

Terms related to this study

Keywords Provided by Researchers

  • Lung cancer screening (LCS)
  • Pink and Pearl Campaign
  • Breast cancer screening (BCS)
  • Low-dose computed tomography (LDCT)
  • Smoking history
  • Health disparities
  • Screening behavior
  • Feasibility
  • Acceptability
  • Appropriateness

Additional Relevant MeSH Terms

  • Lung Cancer
  • Cancer of the Lung